Journals / Türk Hematoloji Onkoloji Dergisi / 2004 / Cilt: 14 - Sayı: 2

Central venous access system complications in patients with solid tumors

Kanserli hastalarda uzun süreli kalıcı santral venöz kateter komplikasyonları

Pages
90–95
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The central venous catheters are the venous access systems which facilitate the treatment with a rate of low complication in patients with solid tumors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate the efficacy and complications of central venous access systems in patients with solid tumors.
📊
Key Findings & Data:All data such as the patient's age, performance status, tumor type, stage, comorbidity, type of chemotherapy and catheter, catheter duration and early and late complications were collected.
💡
Conclusion & Impact:The central venous catheters are the venous access systems which facilitate the treatment with a rate of low complication in patients with solid tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kateterizasyon · santral venöz · Neoplazmlar

Abstract

To evaluate the efficacy and complications of central venous access systems in patients with solid tumors. External and implantable central venous catheters were implanted in patients who would receive chemotherapy for cancer. All data such as the patient's age, performance status, tumor type, stage, comorbidity, type of chemotherapy and catheter, catheter duration and early and late complications were collected. Totally, 114 central venous catheters were implanted to 112 patients who had various solid tumors. Most of the patients (82/112, 73.2%) had colorectal cancer. Totally 101 (88.6%) external and 13 (11.4%) implantable central venous catheters were used. The median follow-up was 157.7±64.6 days with a total of 18342 days. Complications were observed in 15 (13.1%) of 114 catheters, and 13 of them were external catheters. Six and 9 complications were early and late complications respectively. The most frequent complication observed in whole group was malfunction. The total complication rate was 0.076/100 days. The central venous catheters are the venous access systems which facilitate the treatment with a rate of low complication in patients with solid tumors.

Özet

Kanserli hastalarda kullanım sıklığı giderek artan santral venöz kateterlerin uygulaması ve komplikasyonlarına ilişkin sonuçlarımızı sunmak amaçlanmıştır. Solid tümörleri nedeniyle infüzyonel kemoterapi uygulanan 112 hastaya toplam 114 santral venöz kateter (SVK) (eksternal ve implantabl kateter) takıldı. Hastalar yaş, performans durumu, tümör tipi, evresi, komorbidite, aldıkları tedavi türü, kateter tipi, takılma şekli, süresi ve komplikasyonları (erken ve geç) bakımından değerlendirildi. Çoğunluğunu (82 hasta, %73.2) kolorektal tümörlü hastaların oluşturduğu 112 solid tümörlü hastaya 101 (%88.6) eksternal ve 13 (%11.4) implantabl olmak üzere toplam 114 SVK takıldı. Median kateter taşıma süresi 157.7±64.6 gün, toplam kateter izleme süresi 18342 gün idi. Kateterlerden 15 (%13.1)'inde komplikasyon gelişti. Bunların 13'ü eksternal SVK olup, 6 (%5.2)'sı erken, 9 (%7.9)'u da geç komplikasyon şeklindeydi. Hem erken hem de geç komplikasyonları n içinde en sık izleneni malfonksiyon idi. Total komplikasyon hızı 0.076/100 kateter günü idi. Solid tümörlü hastalarda SVK düşük komplikasyon oranına sahip, tedavi kolaylığı sağlayan venöz giriş sistemleridir.

🔖

Cite This Article

ÖZTOP, İ., YAVUZŞEN, T., YILMAZ, U., ÇAVDAR, C., YAREN, A., TARHAN, M. O., MEYDAN, N., SÖKMEN, S., ÇAMSARI, T., ALAKAVUKLAR, M. (2004). Central venous access system complications in patients with solid tumors. Türk Hematoloji Onkoloji Dergisi, Cilt: 14 - Sayı: 2, 90–95. https://ajindex.com/articles/402089

References (13)

  1. Maki DG, Saltz SM, Wheeler S, Mermel LA. Prevention of venous catheter-related blood stream infection by use of an antiseptic-impregnated catheter: a randomised, controlled trial. Ann Intern Med 127:257-66, 1997
  2. Broviac JW, Cole JJ, Schribner BH. A silicone rubber atrial catheter for prolonged parenteral hyperalimentation. Surg Gynecol Obstet 136:602-6, 1973
  3. Hickman RO, Buchner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148:871-75, 1979
  4. Gyves J, Ensminger W, Niederhuber J, et al. Totaly implanted system for intravenous chemotherapy in patients with cancer. Am J Med. 73:841-45, 1982
  5. Biffi R, De Braud F, Orsi F, Pozzi S et al. A randomized, prospective trial of central venous ports connected to standard open-ended or groshong catheters in adult oncology patients. Cancer 92:1204-12,2001
  6. Mueller BU, Skelton J, Callender DPE, Marshall D, Gress J, Lango D, Mortan J, Rubin M, Venzon D, Pizzo PA. A prospective randomized trial comparing the infections and noninfections complications of on externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943-48, 1992
  7. Dawson S, Pai MKR, Smith S, et al. Right atrial catheters in children with cancer: A decade of experience in the use of tunnelled, exteriorized devices at a single institution. Am J Pediatr Hematol Oncol 13: 126-129, 1991
  8. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13: 130-136, 1991
  9. Hockenberry MJ, Schultz WH, Bennett B, et al. Experience with minimal complications in implanted catheters in children. Am J Pediatr Hematol Oncol 11: 295-299, 1989
  10. Greoger JS, Lucas AB, Thaler HT, FriedlanderKlar H, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119: 1168- 74,1993
  11. Pasquale MD, Campbell JM, Magnant CM. Groshong versus Hickman catheters. Surg Gynecol Obstet 174:408-10, 1992
  12. Delmore JE, Horbelt DV, Jack BL, et al. Experience with the Groshong long-term central venous catheter. Gynecol Oncol 34:216-8, 1989
  13. Gleeson NC, Fiorica JV, Mark JE, et al. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 5